Differentiating DSM-IV anxiety and depressive disorders in the general population: Comorbidity and treatment consequences |
Author(s):
,Journal/Book: Can J Psychiatry. 2000; 45: 260-441 Maclaren St, Ottawa, Ontario K2H 2P3, Canada. Canadian Psychiatric Assoc. 166-172.
Abstract: Objective: To attempt, for the first time, to apply a positive and differential diagnosis process in the general population during interviews using DSM-IV classification to ascertain the profile and occurrence of concomitant mental disorders. Method: A representative sample of 1832 individuals aged 15 years or older living irt the metropolitan area of Toronto were interviewed by means of telephone interviews. The participation rate was 72.8%. Results: Overall, 13.2% (n = 242) of the sample had either a mood disorder (n = 127; 6.9%) or an anxiety disorder (n = 170, 9.3% at the time of their interview. The prevalence was higher among women (16.5%) than among men (9.7%), with an odds ratio of 1.8. The comorbidity of mood and anxiety disorders was found in 3% (n = 55) of the sample. Less than one-third of respondents with a mood and/or anxiety disorder were being treated by a physician for a mental disorder. However, these individuals were greater consumers of health care services. Most of them consulted a physician an average of 5 times in the past year. Individuals on medication diagnosed with a mood and art anxiety disorder consulted a physician an average of 12 times in the past year. Only 13% of them were treated with antidepressants and under 9% with anxiolytics. Conclusions: More than 70% of subjects with a mood disorder also complained of insomnia With the differential process, 12% of the subjects manifesting a full-fledged anxiety disorder were diagnosed with only a mood disorder because the anxiety occurred only in the course of the mood disorder. About two-thirds of the subjects diagnosed in this study were undiagnosed and untreated by their physician.
Note: Article Ohayon MM, Stanford Univ, Sch Med, Sleep Disorders Ctr, Dept Psychiat & Behav Sci, 401 Quarry Rd, Suite 3301, Stanford,CA 94305 USA
Keyword(s): anxiety disorders; DSM-IV; epidemiology; mood disorders; sleep complaint; MAJOR DEPRESSION; PSYCHIATRIC-DISORDERS; PSYCHOTROPIC MEDICATION; MENTAL-DISORDERS; SLEEP DISORDERS; PANIC ATTACKS; UNITED-STATES; PREVALENCE; LIFETIME; INSOMNIA
© Top Fit Gesund, 1992-2024. Alle Rechte vorbehalten – Impressum – Datenschutzerklärung